• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A new neurofeedback strategy to treat pain

Bioengineer by Bioengineer
August 13, 2020
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A novel neurofeedback treatment may help to treat chronic pain in the future

IMAGE

Credit: (c) Current Biology

Chronic pain is one of the most important health priorities of the 21st century, with a socioeconomic cost that may far exceed other most other medical problems. It is the leading reason why people stop working prematurely, and a leading cause of loss of independence in the elderly leading to requirements for care. And the magnitude of the problem continues to increase as society ages. The lack of effective drugs for pain has led to an urgency to develop new treatments, with technology-based approaches being an potentially important avenue for innovation.

A new approach to treating a range of neurological and psychiatric treatments is Decoded Neurofeedback (DecNef), in which patients aim to control how information is encoded in their brain using neurofeedback of their brain activity measured using functional neuroimaging. The AMED Nou-Pro project has been exploring applications of DecNef to several conditions, and here we report a preliminary study into the feasibility of using DecNef to control pain.

The study, published in the forthcoming issue of Current Biology, is a preclinical study that aimed to see if pain is potentially controllable by DecNef. We designed a new type of DecNef paradigm, in which volunteers had to try and make the pain ‘clearer’ in their mind, to help a computer read how much pain they were in by studying their brain activity. If the computer could read their pain well, it could work out how to give them less pain later in the experiment.

We found subjects were not easily able to directly control their pain activity in the brain, suggesting that conventional DecNef for pain might be difficult. But instead we found that DecNef had a different effect: it seemed to be boosting the brains’ natural ability to control pain – by enhancing a system caused the ‘endogenous pain control system’. This system is the system that normally tunes how much pain is felt, and allows us to naturally reduce our pain in a wide variety of everyday situations. Importantly, this system seems to be dysfunctional in chronic pain, and so DecNef might provide a way to boost this system to treat pain.

###

Media Contact
Mieko Namba
[email protected]

Tags: Medicine/HealthPain
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Serum Markers Predict Atrial Fibrillation in Diabetes

August 2, 2025
blank

Amyloid Fibrils Connect CHCHD10, CHCHD2 to Neurodegeneration

August 2, 2025

Mapping the Human Hippocampus: Single-Nucleus to Spatial Transcriptomics

August 2, 2025

Boosting ADMET Predictions for Key CYP450s

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    45 shares
    Share 18 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Serum Markers Predict Atrial Fibrillation in Diabetes

Intrapleural Anti-VEGF Boosts Nab-Paclitaxel Efficacy

Amyloid Fibrils Connect CHCHD10, CHCHD2 to Neurodegeneration

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.